CorMedix (CRMD) EBIT Margin (2015 - 2026)
CorMedix (CRMD) posted EBIT Margin of 42.10% for Q2 2026, down 7.09 percentage points from 49.18% a year earlier.
Powered by 
Analysis
CorMedix (CRMD) EBIT Margin (2015 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBIT Margin at CorMedix was 46.17%, up 5.57 percentage points year-over-year; for FY2025, it came in at 48.17%, up 99.59 percentage points from FY2024.
- Annual EBIT Margin shows a five-year change of +11426.61 percentage points (FY2020 to FY2025).
- In prior years, CorMedix's EBIT Margin was -51.43% in FY2024, -46819.91% in FY2022 (-31402.40 pp) and -15417.51% in FY2021 (-4039.08 pp).
- The Q2 2026 figure stands as the lowest quarterly EBIT Margin since Q4 2024.
- On a year-over-year basis, EBIT Margin increased in three of the last four quarters, with an average year-over-year change of +505.66 percentage points.
- The strongest year-over-year quarter for EBIT Margin in the past five years was Q2 2022, with a gain of 33040.22 percentage points; the weakest was Q1 2022, with a drop of 83925.29 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 37.40% |
| 10 | CorMedix | 598.04 Mn | -54.48 Mn | 77.13 Mn | 42.10% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 42.10% |
| Dec 31, 2025 | 45.97% |
| Sep 30, 2025 | 49.24% |
| Jun 30, 2025 | 49.18% |
| Mar 31, 2025 | 51.50% |
| Dec 31, 2024 | 41.45% |
| Sep 30, 2024 | -28.70% |
| Jun 30, 2024 | -1,898.09% |
| Dec 31, 2022 | -28,244.66% |
| Sep 30, 2022 | -102,126.07% |
| Jun 30, 2022 | -38,773.09% |
| Mar 31, 2022 | -92,094.83% |
| Dec 31, 2021 | -13,794.92% |
| Sep 30, 2021 | -22,487.18% |
| Jun 30, 2021 | -71,813.31% |
| Mar 31, 2021 | -8,169.54% |
| Dec 31, 2020 | -10,921.20% |
| Sep 30, 2020 | -7,099.29% |
| Jun 30, 2020 | -54,251.71% |
| Mar 31, 2020 | -7,577.91% |
API Access
CorMedix EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=CRMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "CRMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=CRMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();